Markets:

Overview

News

Currencies

International

Treasuries

Myovant Sciences Ltd. Common Shares (NY:MYOV)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Myovant Sciences Ltd. Common Shares

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 03, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

Myovant Sciences Ltd. (MYOV) Q2 2021 Earnings Call Transcript ↗

October 26, 2021

MYOV earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat? ↗

October 26, 2021

Tucked in its Q2 earnings release, Myovant Sciences Ltd (NYSE: MYOV) said that Pfizer Inc (NYSE: PFE) has notified its option decision for international...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,...

Via Benzinga

Myovant Sciences Earnings Perspective: Return On Capital Employed ↗

October 26, 2021

According to Benzinga Pro data, during Q2, Myovant Sciences (NYSE:MYOV) posted sales of $77.90 million. Earnings were up 67.99%, but Myovant Sciences still reported an overall...

Via Benzinga

Earnings Scheduled For October 26, 2021 ↗

October 26, 2021

Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Earnings Scheduled For July 28, 2021 ↗

July 28, 2021

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United...

Via Benzinga

The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children ↗

October 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion....

Via Benzinga

Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More ↗

September 25, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The week's most notable insider buys were at two...

Via Benzinga

3 Stocks Insiders Are Buying ↗

September 13, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

3 Stocks Insiders Are Buying ↗

September 07, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

The Past Week's Notable Insider Buys: Cano Health, Cricut, GoodRx, SelectQuote And More ↗

September 04, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window...

Via Benzinga

3 Stocks Insiders Are Buying ↗

August 27, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

3 Stocks Insiders Are Buying ↗

August 23, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More ↗

August 21, 2021

With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week.

Via Talk Markets

The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More ↗

August 21, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

Myovant Sciences Ltd. (MYOV) Q1 2021 Earnings Call Transcript ↗

July 28, 2021

MYOV earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Here's Why Myovant Sciences Stock Is Falling Today ↗

July 28, 2021

Second-quarter earnings results were a little bit disappointing.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 28, 2021

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 45.98% to $2.22 during Wednesday's regular session. As of 12:30 EST, this security is trading at...

Via Benzinga

Recap: Myovant Sciences Q1 Earnings ↗

July 28, 2021

Shares of Myovant Sciences (NYSE:MYOV) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 81.08% year...

Via Benzinga

Myovant Sciences's Earnings: A Preview ↗

July 27, 2021

On Wednesday, July 28, Myovant Sciences (NYSE:MYOV) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release....

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Europe OK's Myovant's Relugolix Combo Therapy For Uterine Fibroids ↗

July 20, 2021

The European Commission (EC) has approved Myovant Sciences Ltd's (NYSE: MYOV) Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 08, 2021

Gainers Dare Bioscience (NASDAQ:DARE) sto...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Myovant Sciences Ltd. Common Shares (NY:MYOV)

All News about Myovant Sciences Ltd. Common Shares

Starting at $3.75/week.

Subscribe Today